Literature DB >> 6416574

Charcoal haemoperfusion and haemodialysis in acute intermittent porphyria.

A C Laiwah, B Junor, G J MacPhee, G G Thompson, K E McColl.   

Abstract

Charcoal haemoperfusion has been advocated as a means of removing delta aminolaevulinic acid, which accumulates in attacks of acute intermittent porphyria. A woman presented with acute intermittent porphyria unresponsive to conventional treatment and with pain that was difficult to control. Charcoal haemoperfusion was performed in series with haemodialysis for two hours daily on four consecutive days. Although during this treatment serum and urinary concentrations of delta aminolaevulinic acid and porphobilinogen were considerably reduced, they had returned to pretreatment values 24 hours after the end of treatment. Abdominal pain was not relieved. Although a longer course of treatment might have had a more favourable outcome, this seems unlikely in view of the rapid rebound of serum concentration of delta amino-laevulinic acid after each haemoperfusion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416574      PMCID: PMC1549891          DOI: 10.1136/bmj.287.6407.1746

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  5 in total

1.  Treatment with haematin in acute hepatic porphyria.

Authors:  K E McColl; M R Moore; G G Thompson; A Goldberg
Journal:  Q J Med       Date:  1981

2.  The adsorption of porphyrins and porphyrin precursors by sorbents: a potential therapy for the porphyrias.

Authors:  P V Tishler; B J Gordon; J A O'Connor
Journal:  Methods Find Exp Clin Pharmacol       Date:  1982

3.  Sorbent therapy of the porphyrias. II. Experimental plasma or hemoperfusion with a commercial charcoal cartridge.

Authors:  P V Tishler; B J Gordon
Journal:  Methods Find Exp Clin Pharmacol       Date:  1983

4.  Solute, amino acid, and hormone changes with coated charcoal hemoperfusion in uremia.

Authors:  J F Winchester; J G Ratcliffe; E Carlyle; A C Kennedy
Journal:  Kidney Int       Date:  1978-07       Impact factor: 10.612

5.  Pathogenesis and treatment of acute intermittent porphyria: discussion paper.

Authors:  A C Laiwah; A Goldberg; M R Moore
Journal:  J R Soc Med       Date:  1983-05       Impact factor: 18.000

  5 in total
  1 in total

1.  Effects of hemin and hemodialysis in a patient with acute intermittent porphyria and renal failure.

Authors:  Shirin Attarian; Chunli Yu; Karl E Anderson; Ellen W Friedman
Journal:  Blood Adv       Date:  2017-06-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.